YO-01027 , ≥97% , 209984-56-5
Synonym(s):
DBZ;Dibenzazepine;GSI-XX;N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-benzeneacetamide;γ-Secretase inhibitor XX
CAS NO.:209984-56-5
Empirical Formula: C26H23F2N3O3
Molecular Weight: 463.48
MDL number: MFCD12828734
Pack Size | Price | Stock | Quantity |
2MG | RMB319.20 | In Stock |
|
5MG | RMB591.20 | In Stock |
|
25MG | RMB2303.20 | In Stock |
|
50mg | RMB4151.20 | In Stock |
|
100mg | RMB7199.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 257-259?C |
Boiling point: | 801.3±65.0 °C(Predicted) |
Density | 1.35 |
storage temp. | -20°C |
solubility | DMSO: soluble15mg/mL, clear |
form | White solid |
pka | 12.76±0.20(Predicted) |
color | white to beige |
InChIKey | QSHGISMANBKLQL-OWJWWREXSA-N |
Description and Uses
γ-
γ-Secretase is a multi-subunit aspartyl protease that cleaves amyloid precursor protein (APP) and many other type 1 transmembrane proteins, including Notch, E-cadherin, and ErbB4. The proteolysis of APP by secretases produces beta amyloid (Aβ), a 39- to 42-amino acid peptide which forms the amyloid plaques that are characteristic of Alzheimer’s disease. DBZ is a dipeptidic inhibitor of γ-secretase that potently blocks the cleavage of Notch into its active signaling effector, Notch intracellular domain, in human T cell lymphoma (SupT1) cells (IC50 = 1.7 nM). Within 4 hours after a single 100 μM/kg dose, DBZ demonstrates anti-Alzheimer activity in an APP transgenic mouse model characterized by high levels of Aβ40 by reducing Aβ40 levels by 71%.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H335-H315-H319 |
Precautionary statements | P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26 |
WGK Germany | 3 |
HS Code | 29337900 |